Neutrophil PRV-1 Expression Across the Chronic Myeloproliferative Disorders and in Secondary or Spurious Polycythemia

Blood - United States
doi 10.1182/blood-2003-10-3505
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Intracellular Growth Factors in Polycythemia Vera and Other Myeloproliferative Disorders.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1987English

Sex Differences in the JAK2V617F Allele Burden in Chronic Myeloproliferative Disorders

Haematologica
Hematology
2010English

The Importance of Altered Hematopoietic Microenvironmental Regulation in Chronic Myeloproliferative Disorders

Journal of Hematology & Thromboembolic Diseases
2017English

Lymphoproliferative Disorders in Patients With Chronic Myeloproliferative Neoplasms: A Systematic Review

American Journal of Hematology
Hematology
2018English

Loss of Heterozygosity Identifies Genetic Changes in Chronic Myeloid Disorders, Including Myeloproliferative Disorders, Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Modern Pathology
Forensic MedicinePathology
2007English

Pathogenesis of Myeloproliferative Disorders

Annual Review of Pathology: Mechanisms of Disease
MedicineForensic MedicinePathologyPlant Science
2016English

Secondary Polycythemia and the Risk of Venous Thromboembolism

Journal of Clinical Medicine Research
2014English

Von Willebrand Factor in Myeloproliferative Disorders

Blood & Vessel
1980English

Epigenetics and Mutations in Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy